Autoimmune Encephalitis CT

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Julinka Auta Fernandes

Autoimmune Encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune Encephalitis from Other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Clinical Diagnostic Criteria

Antibody-Negative Autoimmune Encephalitis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Electroencephalography

Other Diagnostic Studies

Screening for an Associated Neoplasm

Pediatric Considerations

Treatment

Medical Therapy

Symptomatic and Supportive Therapy

Interventions

Surgery

Pediatric Treatment Considerations

Rehabilitation

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune Encephalitis On the Web

Most Recent Articles

Google Scholar Articles

Review Articles

Published Guidelines and Consensus Statements

2016 Clinical Diagnostic Criteria

2024 Canadian Adult Consensus Guidelines

2026 UK Adult Encephalitis Guidelines

Pediatric Diagnostic Recommendations

Pediatric NMDAR Treatment Consensus

CME Resources

PowerPoint Slides

Images

MRI Images

Clinical Trials

NICE Search

FDA Resources

CDC Resources

Autoimmune Encephalitis in the News

Hospitals and Neurology Services

Risk Factors and Prognosis Studies

Overview

Autoimmune encephalitis has no specific diagnostic computed tomography (CT) appearance. Brain CT has limited sensitivity for autoimmune encephalitis, and a normal scan does not exclude the disease. In an acute presentation, head CT is principally useful for investigating alternative structural causes of symptoms or major intracranial complications.[1][2]

CT of the chest, abdomen, and pelvis has a separate role in investigating an associated neoplasm in appropriate adults. Finding a tumor can support a paraneoplastic explanation in the correct clinical setting, but does not by itself establish autoimmune encephalitis.[3]

Key CT Findings in Autoimmune Encephalitis

Head CT

In autoimmune encephalitis, head CT may be normal despite clinically significant disease. There is no CT pattern that reliably identifies a particular neuronal antibody or establishes the diagnosis.[1]

For an adult presenting with altered mental status and suspected intracranial pathology or a focal neurological deficit, the American College of Radiology rates noncontrast head CT as usually appropriate initial imaging. This is emergency assessment guidance, rather than a recommendation that CT can diagnose autoimmune encephalitis.[2]

The principal questions include whether there is:

An abnormality requires interpretation on its own merits. It should not automatically be attributed to autoimmune inflammation, and a normal scan does not end the encephalitis investigation.[2][1]

Contrast-Enhanced Body CT

In autoimmune encephalitis, contrast-enhanced CT of the chest, abdomen, and pelvis is a reasonable initial neoplasm-screening investigation in appropriate adults. It can locate a mass and define its extent, helping plan biopsy or subsequent specialist assessment.[3]

Relevant associated tumors include small cell lung cancer, thymic neoplasms, breast cancer, ovarian tumors, testicular germ-cell tumors, and lymphoma. The likelihood and type of tumor vary with age, clinical phenotype, antibody association, and other cancer risk factors.[3]

The 2024 Canadian adult consensus recommends initial neoplasm screening without waiting for neural antibody results. CT findings should therefore be interpreted as part of a coordinated tumor investigation, rather than as a substitute for clinical assessment.[4]

Computed tomography showing a fat-containing ovarian teratoma with a dense internal component. General educational example of an associated tumor; this patient is not documented as having autoimmune encephalitis. Image by Hellerhoff, Wikimedia Commons, licensed under Creative Commons Attribution–ShareAlike 3.0.[5]

Limitations of CT

In autoimmune encephalitis, CT has important limitations:

  • Limited sensitivity for brain inflammation: a normal head CT cannot rule out autoimmune encephalitis.
  • Incomplete tumor detection: a negative body CT does not exclude an occult neoplasm. CT-based screening has limited sensitivity for some early breast and testicular cancers.
  • Patient-specific suitability: radiation exposure and iodinated contrast must be considered. CT is not the preferred screening approach in some groups, including children and pregnant patients; renal impairment or a previous contrast reaction may also alter the plan.[1][3]

Further tumor investigation after a negative CT depends on the clinical and antibody-associated risk. Repeat screening should be individualized, particularly in patients with higher-risk antibodies, refractory or relapsing disease, or other significant cancer risk factors; there is no single repeat-CT schedule appropriate for every patient.[4]

References

  1. ↑ 1.0 1.1 1.2 1.3 Sanvito F, Pichiecchio A, Paoletti M, et al. Autoimmune encephalitis: what the radiologist needs to know. Neuroradiology. 2024;66(5):653–675. doi:10.1007/s00234-024-03318-x. PMID:38507081.
  2. ↑ 2.0 2.1 2.2 American College of Radiology. ACR Appropriateness Criteria: Altered Mental Status, Coma, Delirium, and Psychosis. Revised 2024.
  3. ↑ 3.0 3.1 3.2 3.3 Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. Journal of Neurology, Neurosurgery & Psychiatry. 2021;92(7):757–768. doi:10.1136/jnnp-2020-325300. PMID:33649022.
  4. ↑ 4.0 4.1 Hahn C, Budhram A, Alikhani K, et al. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults. Canadian Journal of Neurological Sciences. 2024;51(6):734–754. doi:10.1017/cjn.2024.16. PMID:38312020.
  5. ↑ Hellerhoff. Teratom 001-03.png. Wikimedia Commons. January 12, 2011. Original work. Licensed under Creative Commons Attribution–ShareAlike 3.0. Accessed November 5, 2026.